These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29620216)

  • 1. Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells.
    Lin CC; Lo MC; Moody RR; Stevers NO; Tinsley SL; Sun D
    Oncol Rep; 2018 Jun; 39(6):3041-3047. PubMed ID: 29620216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
    Lee CH; Hong HM; Chang YY; Chang WW
    Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
    De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
    Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
    Zhang L; Xu L; Zhang F; Vlashi E
    Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model.
    Akhunzianov AA; Nesterova AI; Wanrooij S; Filina YV; Rizvanov AA; Miftakhova RR
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
    Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
    Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress induces senescence in breast cancer stem cells.
    Zhong G; Qin S; Townsend D; Schulte BA; Tew KD; Wang GY
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1204-1209. PubMed ID: 31109646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting aberrant expression of Notch-1 in ALDH
    Pal D; Kolluru V; Chandrasekaran B; Baby BV; Aman M; Suman S; Sirimulla S; Sanders MA; Alatassi H; Ankem MK; Damodaran C
    Mol Carcinog; 2017 Mar; 56(3):1127-1136. PubMed ID: 27753148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.
    Lamb R; Fiorillo M; Chadwick A; Ozsvari B; Reeves KJ; Smith DL; Clarke RB; Howell SJ; Cappello AR; Martinez-Outschoorn UE; Peiris-Pagès M; Sotgia F; Lisanti MP
    Oncotarget; 2015 Jun; 6(16):14005-25. PubMed ID: 26087309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44.
    Kuo YC; Wang LJ; Rajesh R
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():362-372. PubMed ID: 31147008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer.
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez LE; Gaytan-Cervantes J; Muñoz-Galindo L; Piña-Sanchez P; Martinez-Ruiz G; Torres J; Garcia-Lopez P; Gonzalez-Torres C; Ruiz V; Avila-Moreno F; Velasco-Velazquez M; Perez-Tapia M; Maldonado V
    Sci Rep; 2016 Nov; 6():37340. PubMed ID: 27876836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
    Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
    Fiorillo M; Tóth F; Sotgia F; Lisanti MP
    Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.